377 related articles for article (PubMed ID: 8636444)
41. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
[TBL] [Abstract][Full Text] [Related]
42. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
44. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.
de Keyzer Y; Bertagna X; Lenne F; Girard F; Luton JP; Kahn A
J Clin Invest; 1985 Nov; 76(5):1892-8. PubMed ID: 2997296
[TBL] [Abstract][Full Text] [Related]
45. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
[TBL] [Abstract][Full Text] [Related]
46. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors.
Dahia PL; Honegger J; Reincke M; Jacobs RA; Mirtella A; Fahlbusch R; Besser GM; Chew SL; Grossman AB
J Clin Endocrinol Metab; 1997 Apr; 82(4):1088-93. PubMed ID: 9100578
[TBL] [Abstract][Full Text] [Related]
47. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
[TBL] [Abstract][Full Text] [Related]
48. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
[TBL] [Abstract][Full Text] [Related]
49. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.
Heaney AP; Fernando M; Yong WH; Melmed S
Nat Med; 2002 Nov; 8(11):1281-7. PubMed ID: 12379847
[TBL] [Abstract][Full Text] [Related]
50. The gene encoding proopiomelanocortin in the dog.
Mol JA; van Mansfeld AD; Kwant MM; van Wolferen M; Rothuizen J
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():77-83. PubMed ID: 1801506
[TBL] [Abstract][Full Text] [Related]
51. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
52. Ectopic ACTH syndrome.
Wajchenberg BL; Mendonça B; Liberman B; Adelaide M; Pereira A; Kirschner MA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):139-51. PubMed ID: 7626446
[TBL] [Abstract][Full Text] [Related]
53. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.
Arnaldi G; Mancini T; Kola B; Appolloni G; Freddi S; Concettoni C; Bearzi I; Masini A; Boscaro M; Mantero F
J Clin Endocrinol Metab; 2003 Dec; 88(12):5834-40. PubMed ID: 14671177
[TBL] [Abstract][Full Text] [Related]
54. Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors.
de Keyzer Y; Lenne F; Bertagna X
Eur J Endocrinol; 1997 Dec; 137(6):715-8. PubMed ID: 9437242
[TBL] [Abstract][Full Text] [Related]
55. Attenuation of corticotropin-releasing hormone and arginine vasopressin responsiveness during late-gestation pregnancy in sheep.
Young SF; Rose JC
Biol Reprod; 2002 Jun; 66(6):1805-12. PubMed ID: 12021066
[TBL] [Abstract][Full Text] [Related]
56. Mass spectrometric analysis of opioid and tachykinin neuropeptides in non-secreting and ACTH-secreting human pituitary adenomas.
Desiderio DM; Kusmierz JJ; Zhu X; Dass C; Hilton D; Robertson JT; Sacks HS
Biol Mass Spectrom; 1993 Jan; 22(1):89-97. PubMed ID: 8381675
[TBL] [Abstract][Full Text] [Related]
57. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome.
DeBold CR; Menefee JK; Nicholson WE; Orth DN
Mol Endocrinol; 1988 Sep; 2(9):862-70. PubMed ID: 2845257
[TBL] [Abstract][Full Text] [Related]
58. Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors.
de Keyzer Y; Lenne F; Massias JF; Vieau D; Luton JP; Kahn A; Bertagna X
J Clin Invest; 1990 Sep; 86(3):871-7. PubMed ID: 2394836
[TBL] [Abstract][Full Text] [Related]
59. Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers.
Qahwash IM; Cassar CA; Radcliff RP; Smith GW
Endocrine; 2002 Jun; 18(1):13-20. PubMed ID: 12166619
[TBL] [Abstract][Full Text] [Related]
60. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas.
Dieterich KD; Gundelfinger ED; Lüdecke DK; Lehnert H
J Clin Endocrinol Metab; 1998 Sep; 83(9):3327-31. PubMed ID: 9745449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
